SBIO
Fund Stats as of 06/22/2018
Symbol SBIO
CUSIP 00162Q 593
ISIN US00162Q5936
Inception Date 12/30/2014
Dividends Paid Annual
Fund Type Exchange Traded Fund
Market Price $38.83
Last Trade Price $38.82
NAV $38.85
NAV Change $0.13
Total Net Assets $227,293,370
Total Market Value $227,456,038
Premium/Discount(%) -0.05%
Difference ($) $-0.02
Volume 25,322
Shares Outstanding 5,850,000
Expenses as of 03/31/2018
Management Fee0.50%
Other Expenses0.00%
Total Operating Expenses0.50%
Fund Resources
Summary Prospectus 
Statement of Additional Information 
Quarterly Fact Sheet 
Statutory Prospectus 
Resource Library  

Daily Fund Holdings 115 total, as of 06/22/2018, subject to change

SecuritySymbolWeight
Agios Pharmaceuticals Inc.AGIO3.57%
Loxo Oncology Inc.LOXO3.51%
FibroGen Inc.FGEN3.45%
Galapagos NVGLPG3.23%
United Therapeutics Corp.UTHR3.22%
Taro Pharmaceutical Industries Ltd.TARO2.99%
Ligand Pharmaceuticals Inc.LGND2.69%
Madrigal Pharmaceuticals Inc.MDGL2.64%
Hutchison China MediTech Ltd.HCM2.63%
Immunomedics Inc.IMMU2.59%
Array BioPharma Inc.ARRY2.59%
GW Pharmaceuticals PLCGWPH2.43%
Spark Therapeutics Inc.ONCE2.13%
Heron Therapeutics Inc.HRTX1.89%
Supernus Pharmaceuticals Inc.SUPN1.88%
Horizon Pharma PLCHZNP1.85%
Aerie Pharmaceuticals Inc.AERI1.77%
Ironwood Pharmaceuticals Inc.IRWD1.69%
Halozyme Therapeutics Inc.HALO1.65%
Emergent BioSolutions Inc.EBS1.64%
Intercept Pharmaceuticals Inc.ICPT1.60%
Ascendis Pharma ASASND1.57%
Enanta Pharmaceuticals Inc.ENTA1.46%
Akcea Therapeutics Inc.AKCA1.42%
Global Blood Therapeutics Inc.GBT1.38%
Arena Pharmaceuticals Inc.ARNA1.36%
Endo International PLCENDP1.35%
Insmed Inc.INSM1.28%
Akorn Inc.AKRX1.27%
MyoKardia Inc.MYOK1.22%
Atara Biotherapeutics Inc.ATRA1.18%
AnaptysBio Inc.ANAB1.12%
Acceleron Pharma Inc.XLRN1.09%
PTC Therapeutics Inc.PTCT1.07%
Aimmune Therapeutics Inc.AIMT1.05%
ImmunoGen Inc.IMGN1.03%
G1 Therapeutics Inc.GTHX1.01%
Mirati Therapeutics Inc.MRTX0.95%
Radius Health Inc.RDUS0.89%
Acorda Therapeutics Inc.ACOR0.89%
Pacira Pharmaceuticals Inc.PCRX0.88%
Theravance Biopharma Inc.TBPH0.84%
Apellis Pharmaceuticals Inc.APLS0.78%
Revance Therapeutics Inc.RVNC0.72%
Intersect ENT Inc.XENT0.71%
Flexion Therapeutics Inc.FLXN0.66%
Epizyme Inc.EPZM0.66%
Dynavax Technologies Corp.DVAX0.63%
MacroGenics Inc.MGNX0.62%
Endocyte Inc.ECYT0.61%
Assembly Biosciences Inc.ASMB0.58%
Omeros Corp.OMER0.58%
Rhythm Pharmaceuticals Inc.RYTM0.58%
Dova Pharmaceuticals Inc.DOVA0.57%
Amarin Corp. PLCAMRN0.54%
UroGen Pharma Ltd.URGN0.52%
Cymabay Therapeutics Inc.CBAY0.52%
Rocket Pharmaceuticals Inc.RCKT0.51%
NuCana PLCNCNA0.50%
AMAG Pharmaceuticals Inc.AMAG0.48%
Voyager Therapeutics Inc.VYGR0.47%
Adamas Pharmaceuticals Inc.ADMS0.43%
Fate Therapeutics Inc.FATE0.43%
Odonate Therapeutics Inc.ODT0.43%
MiMedx Group Inc.MDXG0.42%
Aduro Biotech Inc.ADRO0.40%
GlycoMimetics Inc.GLYC0.40%
Progenics Pharmaceuticals Inc.PGNX0.40%
Kura Oncology Inc.KURA0.39%
Five Prime Therapeutics Inc.FPRX0.39%
Akebia Therapeutics Inc.AKBA0.39%
Aclaris Therapeutics Inc.ACRS0.38%
ChemoCentryx Inc.CCXI0.38%
CASI Pharmaceuticals Inc.CASI0.35%
Lannett Co. Inc.LCI0.34%
Depomed Inc.DEPO0.30%
Vericel Corp.VCEL0.29%
Concert Pharmaceuticals Inc.CNCE0.29%
Albireo Pharma Inc.ALBO0.28%
ArQule Inc.ARQL0.26%
Achillion Pharmaceuticals Inc.ACHN0.25%
Savara Inc.SVRA0.24%
Aquinox Pharmaceuticals Inc.AQXP0.23%
Syros Pharmaceuticals Inc.SYRS0.23%
PDL BioPharma Inc.PDLI0.23%
MediciNova Inc.MNOV0.23%
Catalyst Pharmaceuticals Inc.CPRX0.22%
Minerva Neurosciences Inc.NERV0.22%
Kala Pharmaceuticals Inc.KALA0.22%
Corbus Pharmaceuticals Holdings Inc.CRBP0.22%
Paratek Pharmaceuticals Inc.PRTK0.21%
Clearside Biomedical Inc.CLSD0.21%
Corium International Inc.CORI0.21%
Durect Corp.DRRX0.20%
Idera Pharmaceuticals Inc.IDRA0.20%
Ra Pharmaceuticals Inc.RARX0.19%
CTI BioPharma Corp.CTIC0.19%
Kiniksa Pharmaceuticals Ltd.KNSA0.18%
Strongbridge Biopharma PLCSBBP0.18%
Athersys Inc.ATHX0.18%
Allena Pharmaceuticals Inc.ALNA0.18%
resTORbio Inc.TORC0.18%
Jounce Therapeutics Inc.JNCE0.18%
Marinus Pharmaceuticals Inc.MRNS0.17%
Avadel Pharmaceuticals PLCAVDL0.16%
Ardelyx Inc.ARDX0.16%
Immune Design Corp.IMDZ0.14%
Calithera Biosciences Inc.CALA0.12%
Syndax Pharmaceuticals Inc.SNDX0.12%
Tocagen Inc.TOCA0.11%
Catalyst Biosciences Inc.14888D200.08%
Dyax Corp. - CVRDYAX-CVR0.00%
Cash In EscrowESCR.CAS0.05%
State Street Institutional Treasury Plus Money Market FundTPIXX0.05%
Cash and Equivalents-0.08%
Total Net Assets 100.00%
Security
Agios Pharmaceuticals Inc.
Loxo Oncology Inc.
FibroGen Inc.
Galapagos NV
United Therapeutics Corp.
Taro Pharmaceutical Industries Ltd.
Ligand Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc.
Hutchison China MediTech Ltd.
Immunomedics Inc.
Array BioPharma Inc.
GW Pharmaceuticals PLC
Spark Therapeutics Inc.
Heron Therapeutics Inc.
Supernus Pharmaceuticals Inc.
Horizon Pharma PLC
Aerie Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc.
Halozyme Therapeutics Inc.
Emergent BioSolutions Inc.
Intercept Pharmaceuticals Inc.
Ascendis Pharma AS
Enanta Pharmaceuticals Inc.
Akcea Therapeutics Inc.
Global Blood Therapeutics Inc.
Arena Pharmaceuticals Inc.
Endo International PLC
Insmed Inc.
Akorn Inc.
MyoKardia Inc.
Atara Biotherapeutics Inc.
AnaptysBio Inc.
Acceleron Pharma Inc.
PTC Therapeutics Inc.
Aimmune Therapeutics Inc.
ImmunoGen Inc.
G1 Therapeutics Inc.
Mirati Therapeutics Inc.
Radius Health Inc.
Acorda Therapeutics Inc.
Pacira Pharmaceuticals Inc.
Theravance Biopharma Inc.
Apellis Pharmaceuticals Inc.
Revance Therapeutics Inc.
Intersect ENT Inc.
Flexion Therapeutics Inc.
Epizyme Inc.
Dynavax Technologies Corp.
MacroGenics Inc.
Endocyte Inc.
Assembly Biosciences Inc.
Omeros Corp.
Rhythm Pharmaceuticals Inc.
Dova Pharmaceuticals Inc.
Amarin Corp. PLC
UroGen Pharma Ltd.
Cymabay Therapeutics Inc.
Rocket Pharmaceuticals Inc.
NuCana PLC
AMAG Pharmaceuticals Inc.
Voyager Therapeutics Inc.
Adamas Pharmaceuticals Inc.
Fate Therapeutics Inc.
Odonate Therapeutics Inc.
MiMedx Group Inc.
Aduro Biotech Inc.
GlycoMimetics Inc.
Progenics Pharmaceuticals Inc.
Kura Oncology Inc.
Five Prime Therapeutics Inc.
Akebia Therapeutics Inc.
Aclaris Therapeutics Inc.
ChemoCentryx Inc.
CASI Pharmaceuticals Inc.
Lannett Co. Inc.
Depomed Inc.
Vericel Corp.
Concert Pharmaceuticals Inc.
Albireo Pharma Inc.
ArQule Inc.
Achillion Pharmaceuticals Inc.
Savara Inc.
Aquinox Pharmaceuticals Inc.
Syros Pharmaceuticals Inc.
PDL BioPharma Inc.
MediciNova Inc.
Catalyst Pharmaceuticals Inc.
Minerva Neurosciences Inc.
Kala Pharmaceuticals Inc.
Corbus Pharmaceuticals Holdings Inc.
Paratek Pharmaceuticals Inc.
Clearside Biomedical Inc.
Corium International Inc.
Durect Corp.
Idera Pharmaceuticals Inc.
Ra Pharmaceuticals Inc.
CTI BioPharma Corp.
Kiniksa Pharmaceuticals Ltd.
Strongbridge Biopharma PLC
Athersys Inc.
Allena Pharmaceuticals Inc.
resTORbio Inc.
Jounce Therapeutics Inc.
Marinus Pharmaceuticals Inc.
Avadel Pharmaceuticals PLC
Ardelyx Inc.
Immune Design Corp.
Calithera Biosciences Inc.
Syndax Pharmaceuticals Inc.
Tocagen Inc.
Catalyst Biosciences Inc.
Dyax Corp. - CVR
Cash In Escrow
State Street Institutional Treasury Plus Money Market Fund
Cash and Equivalents
Total Net Assets